Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
06/2005
06/23/2005US20050136475 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/23/2005US20050136474 Truncation SELEX method
06/23/2005US20050136462 Method for engineering nicking enzymes
06/23/2005US20050136451 Hypoxia responsive human CNGH 0002 genes and polypeptides
06/23/2005US20050136449 For polypeptides having polyhistidine/polycysteine tags; cell extracts comprising nuclease inhibitors; kits
06/23/2005US20050136433 Using mutation in intron-exon boundary of dihydropyrimidine dehydrogenase as indicator for modifying cancer treatment protocol
06/23/2005US20050136426 Bacterial phytochelatin synthetase
06/23/2005US20050136425 Novel human helicase (NHL) for use as tool in identification of modulators for treatment and prevention of cell proliferative disorders
06/23/2005US20050136424 New class of bacterial AB5 toxin having a subtilase domain (A) and B subunit able to recognize cell surface oligosaccharide component GM2; cytotoxic to Vero cells; toxicity in vivo in mice occurs at different sites; mutation of the serine active residue results in > 99% activity reduction
06/23/2005US20050136415 detecting the presence of a biomarker; presence of A nucleotides at nucleotide 102 in both alleles is indicative of the horse being predisposed to or has GSD IV
06/23/2005US20050136407 Genetic polymorphisms in the prostate-specific antigen gene promoter
06/23/2005US20050136400 NS3-NS4A protease resistance mutants
06/23/2005US20050136394 Cell-based assay for identifying peptidase inhibitors
06/23/2005US20050136393 Oligonucleotide primers inserted into stranded expression vectors and cell transformed with this
06/23/2005US20050136068 Enzymatically inactive streptococcal C5a peptidase (SCP) conjugated or linked to one or more peptides; effective in immunizing a susceptible mammal against beta-hemolytic Streptococcus
06/23/2005US20050136062 Treatment of IgA1 deposition diseases
06/23/2005US20050136045 Can be administered by continuous infusion or by single intravenous bolus injection; use in the treatment of arterial thrombosis and for treating myocardial infarction; reduced antigenicity and immunogenicity as compared to wild-type staphylokinase
06/23/2005US20050136044 Exhibit increased ability to convert chemotherapeutic agent pro-drugs into active drugs; provide treatment options for cancer
06/23/2005DE10355302A1 Verfahren zur fermentativen Anreicherung von Lebensmitteln mit Fructose-Oligosacchariden Process for the fermentative fortification of foods with fructose oligosaccharides
06/23/2005DE10354779A1 Oxidoreduktase aus Metschnikowia zobellii Oxidoreductase from Metschnikowia zobellii
06/23/2005DE10354403A1 Gegen das Prothrombin-Fragment F 1+2 gerichtete Antikörper, ihre Herstellung und Verwendung Against the prothrombin fragment 1 + F 2 directed antibody, their preparation and use
06/23/2005DE102004055686A1 New modified sarcosine oxidase, useful as diagnostic reagent for measuring creatinine or creatine, has reduced activity on N-ethylglycine, also nucleic acid that encodes it
06/23/2005CA2549710A1 Polynucleotides and polypeptides isolated from lactobacillus rhamnosus hn001 materials incorporating them and methods for using them
06/23/2005CA2549482A1 Megsin/rage/inos overexpressing renaldisease model animals and methods for evaluating compounds using the model animals
06/23/2005CA2549384A1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis
06/23/2005CA2549291A1 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune
06/23/2005CA2549164A1 Self-assembling peptide amphiphiles and related methods for growth factor delivery
06/23/2005CA2548953A1 Nitroreductase biosensors for detecting nitro-compounds
06/23/2005CA2548899A1 Marine algae extract and lipase inhibitor containing the same
06/23/2005CA2548530A1 Charcoal stabilization of phenyl phosphates
06/23/2005CA2548030A1 Wheat having reduced waxy protein due to non-transgenic alterations of a waxy gene
06/23/2005CA2547709A1 Perhydrolase
06/23/2005CA2547381A1 Marine algae extract and glycosidase inhibitor containing the same
06/23/2005CA2546914A1 Production of amino sugars
06/23/2005CA2543257A1 Methods and compositions for delivering polynucleotides
06/23/2005CA2453976A1 Method of detecting equine glycogen storage disease iv
06/22/2005EP1544304A1 Novel serine protease
06/22/2005EP1544303A2 Modification of plant metabolism
06/22/2005EP1544302A1 KNOCKIN NONHUMAN ANIMAL AND TISSUE-SPECIFIC MnSOD-KNOCKOUT NONHUMAN ANIMAL
06/22/2005EP1544301A1 DNA molecules that code for enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing said molecules
06/22/2005EP1544300A1 Novel glycosyltransferase genes
06/22/2005EP1544295A1 Salt-inducible kinases 2 and use thereof
06/22/2005EP1544293A1 Antibody against enzyme specifically cleaving von villebrand factor and assay system using the same
06/22/2005EP1544292A1 Glucose dehydrogenase
06/22/2005EP1544291A1 Novel process for producing antibody enzyme, novel antibody enzyme and utilization thereof
06/22/2005EP1543332A2 Protein arrays and uses thereof
06/22/2005EP1543327A2 Method for assaying compounds or agents for ability to decrease the activity of microsomal prostaglandin e synthase or hematopoietic prostaglandin d synthase
06/22/2005EP1543324A2 Methods and compositions for grafting functional loops into a protein
06/22/2005EP1543139A1 Recombinant microorganism for the production of vitamin b6
06/22/2005EP1543137A1 Process for producing vitamin c
06/22/2005EP1543132A2 Production of canthaxanthin by phaffia
06/22/2005EP1543130A2 Diacylglycerol acyltransferase nucleic acid sequences and associated products
06/22/2005EP1543127A2 Nucleic acid sequences coding for proteolytic enzymes in the form of specific proteases, corresponding polypeptides and use of the same
06/22/2005EP1543126A2 A GENE ENCODING VITAMIN B sb 6 /sb PHOSPHATE PHOSPHATASE AND USE THEREOF
06/22/2005EP1543125A2 Enone reductase gene and microbial production of levodione
06/22/2005EP1543124A1 Dna encoding flavin-adenine-dinucleotide-dependent-d-erythronate-4-phosphate-dehydrogenase , pdxr , and microbial production of vitamin b6
06/22/2005EP1543123A2 Acc gene
06/22/2005EP1543118A1 Crystal structure of chorismate synthase and uses thereof
06/22/2005EP1543117A2 High throughput mutagenesis screening method
06/22/2005EP1543116A2 Hemipteran myosin light chain kinase
06/22/2005EP1543115A2 Squalene synthase (sqs) gene
06/22/2005EP1543114A2 Aldehyde dehydrogenase gene
06/22/2005EP1543112A1 Regulating beta-catenin levels
06/22/2005EP1543105A1 New mutant strains of pseudomonas fluorescens and variants thereof, methods for their production, and uses thereof in alginate production
06/22/2005EP1543104A1 Microorganism and process for preparing vitamin b6
06/22/2005EP1543025A2 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
06/22/2005EP1543024A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
06/22/2005EP1542998A2 Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b
06/22/2005EP1542945A2 Method for the production of zeaxanthin and/or the biosynthetic intermediates and/or subsequent products thereof
06/22/2005EP1542710A1 Methods for preserving organs and tissues
06/22/2005EP1542538A2 Lipase inhibitors and uses thereof
06/22/2005EP1542527A2 Transgenic high tryptophan plants
06/22/2005EP1414299A4 Substantially homogeneous bio-affecting material having a pre-determined ratio of bioaffecting component to cell targeting component, the method for making such a material and the method of its use
06/22/2005EP1330552A4 Marker assisted selection of bovine for improved milk production using diacylglycerol acyltransferase gene dgat1
06/22/2005EP1261695B1 Methods for making plants tolerant to glyphosate and compositions thereof
06/22/2005EP1165763B1 Hydantoinase variants with improved properties and their use for the production of amino acids
06/22/2005EP1100542B1 Peg-urate oxidase conjugates and use thereof
06/22/2005EP0791066B1 Dna molecules that code for enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing said molecules
06/22/2005EP0670892B1 Purification, composition and specificity of heparinase i, ii, and iii from flavobacterium heparinum
06/22/2005CN1630863A Method for crystallizing human GSK3 and novel crystal structure thereof
06/22/2005CN1630729A Method for the recombination of genetic elements
06/22/2005CN1630726A Beta-lactamase/anminoglycosides modifying enzyme genes, their fusion gene and the expression products, the composition thereof, and their uses in medicine and environmental protection
06/22/2005CN1630721A Factor VII polypeptides for preventing formation of inhibitors in subjects with haemophilia
06/22/2005CN1630720A Bifunctional fusion proteins with glucocerebrosidase activity
06/22/2005CN1630719A Phytase variants
06/22/2005CN1630718A Improved isoprenoid production
06/22/2005CN1630712A Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
06/22/2005CN1630664A Caspase-8 binding protein, its preparation and use
06/22/2005CN1630663A Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses
06/22/2005CN1630518A Methods of treating and preventing bone loss
06/22/2005CN1629286A 猪单胺氧化酶a蛋白编码序列 Pig a monoamine oxidase protein coding sequence
06/22/2005CN1207390C Process for efficiently expressing high-temp element S oxido-reductase gene
06/22/2005CA2465009A1 Cytotoxin with a subtilase domain
06/21/2005US6908993 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents
06/21/2005US6908992 Isolated from methylomonas encoding 2-keto-3-deoxy-6-phosphogluconate/fructose bisphosphate aldolase; pyrophosphate dependent phosphofructokinases
06/21/2005US6908991 Mutants; detergents; active materials; oxidation resistance
06/21/2005US6908984 Megakaryocytic protein tyrosine kinase I
06/21/2005US6908758 Human kinase proteins and polynucleotides encoding the same
06/21/2005US6908757 Serine protease variants having amino acid deletions and substitutions
06/21/2005US6908756 For production of transgenic animal models; for treatment of Alzheimer's disease
1 ... 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 ... 1416